DE69326849T2 - Verwendung von humanem Atrio-natriuretischem Peptid zur Herstellung eines Medikaments zur Behandlung des Atemunwohlseinsyndroms bei Erwachsenen - Google Patents

Verwendung von humanem Atrio-natriuretischem Peptid zur Herstellung eines Medikaments zur Behandlung des Atemunwohlseinsyndroms bei Erwachsenen

Info

Publication number
DE69326849T2
DE69326849T2 DE69326849T DE69326849T DE69326849T2 DE 69326849 T2 DE69326849 T2 DE 69326849T2 DE 69326849 T DE69326849 T DE 69326849T DE 69326849 T DE69326849 T DE 69326849T DE 69326849 T2 DE69326849 T2 DE 69326849T2
Authority
DE
Germany
Prior art keywords
treatment
respiratory distress
distress syndrome
natriuretic peptide
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69326849T
Other languages
English (en)
Other versions
DE69326849D1 (de
Inventor
Masakazu Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daichi Suntory Pharma Co Ltd Tokio/tokyo Jp
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE69326849D1 publication Critical patent/DE69326849D1/de
Publication of DE69326849T2 publication Critical patent/DE69326849T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69326849T 1992-01-09 1993-01-04 Verwendung von humanem Atrio-natriuretischem Peptid zur Herstellung eines Medikaments zur Behandlung des Atemunwohlseinsyndroms bei Erwachsenen Expired - Fee Related DE69326849T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4002424A JP2925391B2 (ja) 1992-01-09 1992-01-09 Ａｒｄｓ治療用医薬組成物

Publications (2)

Publication Number Publication Date
DE69326849D1 DE69326849D1 (de) 1999-12-02
DE69326849T2 true DE69326849T2 (de) 2000-04-20

Family

ID=11528876

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69326849T Expired - Fee Related DE69326849T2 (de) 1992-01-09 1993-01-04 Verwendung von humanem Atrio-natriuretischem Peptid zur Herstellung eines Medikaments zur Behandlung des Atemunwohlseinsyndroms bei Erwachsenen

Country Status (8)

Country Link
US (1) US5418219A (de)
EP (1) EP0551077B1 (de)
JP (1) JP2925391B2 (de)
AT (1) ATE185973T1 (de)
DE (1) DE69326849T2 (de)
DK (1) DK0551077T3 (de)
ES (1) ES2141116T3 (de)
GR (1) GR3032442T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5504111A (en) * 1994-12-30 1996-04-02 Medichem Research, Inc. Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
US5780440A (en) * 1996-06-17 1998-07-14 Protease Sciences Inc. Treatment of pulmonary disease with protease inhibitors
US7583292B2 (en) 1999-12-28 2009-09-01 Sony Corporation Signal processing device and method, and recording medium
IL145926A0 (en) * 2001-10-15 2002-07-25 Mor Research Applic Ltd Peptide epitopes of mimotopes useful in immunomodulation
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
IL155136A0 (en) * 2003-02-10 2003-10-31 Enzymotec Ltd A composition for reducing blood cholesterol and triglycerides
EP1637162A4 (de) * 2003-06-13 2009-07-15 Asubio Pharma Co Ltd Medizinische zusammensetzung zur prävention oder behandlung von immunologischen erkrankungen vom th1 typ
AU2005270825B2 (en) * 2004-08-09 2011-07-07 Enzymotec Ltd. Food products for diabetics
WO2006016363A2 (en) 2004-08-10 2006-02-16 Enzymotec Ltd. Mixture of phytosterol ester(s) and 1, 3-diglyceride(s) for use in the treatment of medical conditions
EP1896500A4 (de) * 2005-06-28 2010-08-11 Yeda Res & Dev Gliomedin, fragmente davon und verfahren zu ihrer anwendung
WO2007030492A2 (en) * 2005-09-06 2007-03-15 Guilford F Timothy Method for the treatment of infection with hhv-6 virus and the amelioration of symptoms related to virus using liposomal encapsulation for delivery of reduced glutathione
US7795221B2 (en) * 2006-03-30 2010-09-14 Palatin Technologies, Inc. Linear natriuretic peptide constructs
US7622440B2 (en) 2006-03-30 2009-11-24 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
US8580746B2 (en) * 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
US20100150924A1 (en) * 2007-05-22 2010-06-17 Elior Peles Regulation of myelination by nectin-like (necl) molecules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60136596A (ja) * 1983-12-26 1985-07-20 Suntory Ltd ペプチド及びこれを有効成分とする利尿剤
DE3443257A1 (de) * 1984-11-28 1986-05-28 Bissendorf Peptide GmbH, 3002 Wedemark Mittel enthaltend vollsynthetisches alpha-humanes atriales natriuretisches peptid (alpha-hanap)
US5043321A (en) * 1988-07-11 1991-08-27 Center For Innovative Technology Adrenocorticotropin release inhibiting factor

Also Published As

Publication number Publication date
ES2141116T3 (es) 2000-03-16
EP0551077A2 (de) 1993-07-14
ATE185973T1 (de) 1999-11-15
JPH05186366A (ja) 1993-07-27
US5418219A (en) 1995-05-23
EP0551077A3 (en) 1994-06-29
DK0551077T3 (da) 2000-04-10
DE69326849D1 (de) 1999-12-02
EP0551077B1 (de) 1999-10-27
GR3032442T3 (en) 2000-05-31
JP2925391B2 (ja) 1999-07-28

Similar Documents

Publication Publication Date Title
DE69326849T2 (de) Verwendung von humanem Atrio-natriuretischem Peptid zur Herstellung eines Medikaments zur Behandlung des Atemunwohlseinsyndroms bei Erwachsenen
BR9507811A (pt) Análogs de pertídeos sintéticos da proteína superficial dos pulmões sp-c
ATE114113T1 (de) Verwendung von droloxifen bei der behandlung von knochenerkrankungen.
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE69202207T2 (de) Verfahren zur Herstellung von 1-Chlor-1,1,3,3,3-Pentafluorpropan und von 1,1,1,3,3,3-Hexafluorpropan.
DE59109222D1 (de) Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen
GR3026369T3 (en) Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist.
DE69214467T3 (de) Verwendung von L-2-oxo Thiazolidin-4-carboxylat zur Behandlung von Atemnotsyndrom
WO1992012715A3 (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
DE3855113D1 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
DE69721120D1 (de) Verwendung von menschlichen Chemokin beta-9 zur Behandlung von Atemnotsyndrom bei Erwachsenen
DK0443848T3 (da) Nyt antiulcermiddel
EP0374089A3 (de) Verwendung von Somatostatinderivaten als Substanzen zum Schutz der Lunge
IL98199A (en) Pharmaceutical compositions containing a derivative of substituted l-valyl-l-prolinamide
ATE235238T1 (de) Verwendung von 2,3- alkylcaebonyloxybenzoesäure zur behandlung des atemunwohlseinsydroms bei erwachsenen
DE69632117D1 (de) Verwendung von 8,9-Dehydroestron zur Herstellung eines Arzneimittels zur Behandlung von durch freie Radikale verursachte Krankheiten
DE69307197T2 (de) Verwendung von 24,25-Dihydroxyvitamin-D3 zur Herstellung eines Arzneimittel zur Behandlung der Rachitis
DE69431320T2 (de) Verwendung von menschlichem Interferon-d zur Herstellung eines Arzneimittels zur Behandlung von Atemwegserkrankungen in Katzen
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.
ITMI910442V0 (it) Struttura di zoccolo ortopedico, o simile, in particolare per la prevenzione o la cura del valgismo dell'alluce
IT1244714B (it) Uso della benzidamina per il trattamento della placca dentaria
DE69133298D1 (de) Verwendung von acetylierten Mannanderivaten zur Behandlung von chronischen Atemwegserkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee